BeiGene, Ltd. - American Depositary Shares (BGNE) earnings
Quarterly and annual BGNE reports and results, each read against the price at its own news timestamp. Back to the BGNE overview →
10 measured BGNE earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-K/A BeiGene, Ltd. For: Dec 31 | SEC filing · Form 10-K | — | — | |
| BeiGene Announces Third Quarter 2024 Financial Results and Corporate Updates | Press release | -1.51% | -2.20% | |
| Form 10-Q BeiGene, Ltd. For: Sep 30 | SEC filing · Form 10-Q | +1.06% | -0.66% | |
| BeiGene Enters Next Phase of Global Growth with Announcement of Second Quarter 2024 Financial Results and Corporate Updates | Press release | -2.07% | -1.82% | |
| Form 10-Q BeiGene, Ltd. For: Jun 30 | SEC filing · Form 10-Q | -2.07% | -1.82% | |
| BeiGene Reports First Quarter 2024 Financial Results and Business Updates | Press release | +1.46% | -0.63% | |
| Form 10-Q BeiGene, Ltd. For: Mar 31 | SEC filing · Form 10-Q | +1.46% | -0.63% | |
| Form 10-K BeiGene, Ltd. For: Dec 31 | SEC filing · Form 10-K | -0.00% | +0.70% | |
| BeiGene Continues Global Growth with Third Quarter 2023 Financial Results and Business Updates | Press release | -0.82% | +2.35% | |
| Form 10-Q BeiGene, Ltd. For: Sep 30 | SEC filing · Form 10-Q | -0.82% | +2.35% |
Keep exploring
More BGNE: analyst actions → · SEC filings → · BGNE overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| TAKEDA PHARMA (TKPYY) | 192 | 0.00% | 47% |
| Arbutus Biopharma Corporation (ABUS) | 191 | +0.11% | 52% |
| CYTODYN INC (CYDY) | 191 | -0.07% | 45% |
| BAVARIAN NORDIC R/I S/ADR (BVNRY) | 190 | 0.00% | 29% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.